Panel member Elizabeth Rebello, a pharmacist and anaesthesiologist, told the committee she had voted no on BPC-157 "because of the lack of efficacy data" and "safety concerns", Reuters news agency reported
Vitamin C, or ascorbic acid, is a water-soluble vitamin that humans cannot produce on their own
Retatrutide is an investigational medicinal product (IMP) accessible only through authorised clinical trials
Dosing Considerations TB-500 requires less frequent dosing than BPC-157 due to its longer half-life
Most of what is known comes from: So when someone searches for BPC 157 weight loss, it is important to set expectations right away: this is not comparable to clinically validated obesity therapies backed by decades of clinical outcome data, standardized dosing, and predictable effects on appetite and metabolic pathways, such as FDA-approved options like semaglutide (Wegovy) and tirzepatide (Zepbound)